Introducing Medisca Nutraceuticals

Download in electronic PDF format for $25



Search the Complete Journal Archives

A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 2

Author(s):  Gillson George R, Zava David T

Issue:  Sep/Oct 2003 - After the Women's Health Initiative Trial
View All Articles in Issue

Abstract:  This second part of a two-part series focuses on a discussion of progesterone and progestins differentiating the two in terms of synergy between estradiol and progesterone, balance between estrone and estrogen sulfate within tumor cells, protection of the uterine linings and impact on cardiovascular function; and bioidentical progesterones (oral and topical). Sidebars provide examples of studies showing adverse effects of medroxyprogesterone acetate on cardiovascular health, progesterone’s beneficial effects on cardiovascular function, results with bioidentical progesterone, results with topical progesterone and a protocol for combined hormone replacement therapy using progesterone skin cream. The authors conclude that physicians should not turn their backs on patients suffering from hormonal deficiencies in the absence of large clinical trials with bioidentical hormones since the literature suggests estradiol and estriol would be good estrogens to use and transdermal delivery of hormones is advantageous over oral delivery. With oral delivery, doctors should rethink dosing and consider impact on other relevant parameters. It appears that certain progestins should be avoided in favor of bioidentical progesterone, and saliva testing can allow monitoring of hormone levels. With good follow-up, clinical judgment and laboratory backup, there is enough information about hormone replacement to offer bioidentical hormone replacement therapy as a viable option. A patient handout on hormone replacement therapy accompanies the article.

Related Keywords: Bioidentical hormone replacement therapy, for women, Estradiol, for women, Estrogen sulfate, for women, Estrone, for women, Hormone replacement therapy, for women, Medroxyprogesterone acetate, and cardiovascular health, Medroxyprogesterone acetate, for women, Progesterone, bioidentical, for women, Progesterone, and cardiovascular function, Progestins, for women

Related Categories: HRT

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 2 Gillson George R, Zava David T Sep/Oct 2003 330 Buy
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1 Cutter Christopher B Jan/Feb 2004 16 Buy
Women's Oral Health: Is There a Hormonal Link? Preckshot John Jan/Feb 2004 10 Buy
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 2 Cutter Christopher B Mar/Apr 2004 96 Buy
The Science Behind Hormone Replacement Therapy, Part 1 Wepfer Scott T Nov/Dec 2001 462 Buy
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K Jan/Feb 2013 74-85 View Sample
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1 Gillson George R, Zava David T Jul/Aug 2003 250 Buy
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1 Deleruyelle Laura J Sep/Oct 2016 359-364 Buy
Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study Moro Doris, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah Mar/Apr 2010 165-170 Buy
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2 Deleruyelle Laura J Nov/Dec 2016 447-454 Buy